Showing results (21-30 of 255) with videos related to
Sort By:
Pageof 26
Bulletin Du Cancer|February 15, 2001
[Telomerase, a universal target in immunotherapy strategies against tumor?]R Rousseau, J C SoriaEuropean Journal of Cancer (Oxford, England : 1990)|November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteriaM Tazdait, L Mezquita, J Lahmar, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2005
mTOR-targeted therapy of cancer with rapamycin derivativesS Vignot, S Faivre, D Aguirre, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Developments in the treatment of early NSCLC: when to use chemotherapyB Besse, T Le ChevalierLung Cancer (Amsterdam, Netherlands)|January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?M Macerelli, C Caramella, L Faivre, et al.Bulletin Du Cancer|May 21, 2010
[Implications of ALK (anaplastic lymphoma kinase) in oncohematology]T Cluzeau, N Pécuchet, N Mounier, et al.Bulletin Du Cancer|February 24, 2010
[Febrile neutropenia in adult patients with solid tumours: a review of literature toward a rational and optimal management]C Even, L Taillade, J-P Spano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 13, 2012
[Improvements of ablative local treatments modify the management of the oligometastatic disease]J Thariat, S Vignot, R-J Bensadoun, et al.Pageof 26